{# Form PF Workpaper Template #}
{# Version: 1.0 #}
{# Purpose: Support documentation for SEC Form PF quarterly filing #}

{# ============================================ #}
{# DOCUMENT HEADER #}
{# ============================================ #}

# Form PF Workpaper

**Fund:** {{ fund_name }}  
**Filing Period:** {{ filing_period_start | date_format }} to {{ filing_period_end | date_format }}  
**As-of Date:** {{ as_of_date | date_format }}  
**Prepared:** {{ prepared_at | datetime_format }}  
**Document ID:** {{ document_id }}  

---

## Filing Overview

| Field | Value |
|-------|-------|
| Form Type | Form PF |
| Filer Type | {{ filer_type }} |
| Reporting Period | Q{{ quarter }} {{ year }} |
| RAUM | {{ regulatory_aum | currency_format }} |
| Filing Deadline | {{ filing_deadline | date_format }} |

---

{# ============================================ #}
{# SECTION 1: REGULATORY AUM CALCULATION #}
{# ============================================ #}

## 1. Regulatory Assets Under Management (RAUM)

### 1.1 AUM Calculation

| Component | Amount | Evidence |
|-----------|--------|----------|
| Gross Asset Value | {{ gross_asset_value | currency_format }} | `{{ gross_av_evidence }}` |
| Less: Borrowings | {{ borrowings | currency_format }} | `{{ borrowings_evidence }}` |
| Net Asset Value | {{ nav | currency_format }} | `{{ nav_evidence }}` |
| Uncalled Commitments | {{ uncalled | currency_format }} | `{{ uncalled_evidence }}` |
| **Regulatory AUM** | **{{ regulatory_aum | currency_format }}** | `{{ raum_evidence }}` |

### 1.2 Calculation Methodology
{{ raum_methodology_narrative }}

**Evidence Hash:** `{{ raum_calculation_evidence }}`

---

{# ============================================ #}
{# SECTION 2: BENEFICIAL OWNERSHIP #}
{# ============================================ #}

## 2. Beneficial Ownership

### 2.1 Investor Breakdown

| Investor Type | Count | % of NAV | Evidence |
|---------------|-------|----------|----------|
{% for investor_type in investor_breakdown %}
| {{ investor_type.type }} | {{ investor_type.count }} | {{ investor_type.pct_nav | percent_format }} | `{{ investor_type.evidence }}` |
{% endfor %}

### 2.2 Geographic Distribution

| Region | % of NAV | Evidence |
|--------|----------|----------|
{% for region in geographic_distribution %}
| {{ region.name }} | {{ region.pct_nav | percent_format }} | `{{ region.evidence }}` |
{% endfor %}

---

{# ============================================ #}
{# SECTION 3: INVESTMENT STRATEGY #}
{# ============================================ #}

## 3. Investment Strategy & Performance

### 3.1 Strategy Classification

| Strategy | Gross Exposure | Net Exposure | % of Fund |
|----------|----------------|--------------|-----------|
{% for strategy in strategies %}
| {{ strategy.name }} | {{ strategy.gross | percent_format }} | {{ strategy.net | percent_format }} | {{ strategy.pct_fund | percent_format }} |
{% endfor %}

### 3.2 Quarterly Performance

| Month | Gross Return | Net Return | Benchmark | Evidence |
|-------|--------------|------------|-----------|----------|
{% for month in quarterly_performance %}
| {{ month.name }} | {{ month.gross_return | percent_format }} | {{ month.net_return | percent_format }} | {{ month.benchmark | percent_format }} | `{{ month.evidence }}` |
{% endfor %}

| **Quarter Total** | {{ quarter_gross | percent_format }} | {{ quarter_net | percent_format }} | {{ quarter_benchmark | percent_format }} | `{{ quarter_evidence }}` |

---

{# ============================================ #}
{# SECTION 4: RISK METRICS #}
{# ============================================ #}

## 4. Risk Metrics (Question 26-42)

### 4.1 Value at Risk

| VaR Measure | Value | Methodology | Evidence |
|-------------|-------|-------------|----------|
| 99% 1-Day VaR | {{ var_99_1d | percent_format }} | {{ var_methodology }} | `{{ var_evidence }}` |
| 95% 1-Day VaR | {{ var_95_1d | percent_format }} | {{ var_methodology }} | `{{ var_evidence }}` |
| 99% 10-Day VaR | {{ var_99_10d | percent_format }} | {{ var_methodology }} | `{{ var_evidence }}` |

### 4.2 Stress Test Results

| Scenario | Impact on NAV | Evidence |
|----------|---------------|----------|
{% for scenario in stress_scenarios %}
| {{ scenario.name }} | {{ scenario.impact | percent_format }} | `{{ scenario.evidence }}` |
{% endfor %}

### 4.3 Leverage

| Leverage Type | Value | Evidence |
|---------------|-------|----------|
| Gross Leverage (GNE) | {{ gross_leverage | number_format(2) }}x | `{{ leverage_evidence }}` |
| Net Leverage | {{ net_leverage | number_format(2) }}x | `{{ leverage_evidence }}` |
| Borrowing Leverage | {{ borrowing_leverage | number_format(2) }}x | `{{ leverage_evidence }}` |

---

{# ============================================ #}
{# SECTION 5: COUNTERPARTY EXPOSURE #}
{# ============================================ #}

## 5. Counterparty Exposure (Question 43-47)

### 5.1 Largest Counterparties

| Rank | Counterparty | Exposure Type | % of NAV | Evidence |
|------|--------------|---------------|----------|----------|
{% for cp in top_counterparties %}
| {{ loop.index }} | {{ cp.name }} | {{ cp.type }} | {{ cp.pct_nav | percent_format }} | `{{ cp.evidence }}` |
{% endfor %}

### 5.2 Counterparty Credit Quality

| Rating | Count | % of Total Exposure |
|--------|-------|---------------------|
{% for rating in counterparty_ratings %}
| {{ rating.rating }} | {{ rating.count }} | {{ rating.pct_exposure | percent_format }} |
{% endfor %}

---

{# ============================================ #}
{# SECTION 6: LIQUIDITY #}
{# ============================================ #}

## 6. Portfolio Liquidity (Question 48-52)

### 6.1 Liquidity Profile

| Liquidation Period | % of Portfolio | Evidence |
|--------------------|----------------|----------|
| T+1 (1 day) | {{ liquidity_t1 | percent_format }} | `{{ liquidity_evidence }}` |
| T+7 (1 week) | {{ liquidity_t7 | percent_format }} | `{{ liquidity_evidence }}` |
| T+30 (1 month) | {{ liquidity_t30 | percent_format }} | `{{ liquidity_evidence }}` |
| T+90 (1 quarter) | {{ liquidity_t90 | percent_format }} | `{{ liquidity_evidence }}` |
| T+180 (6 months) | {{ liquidity_t180 | percent_format }} | `{{ liquidity_evidence }}` |
| T+365+ (1 year+) | {{ liquidity_t365 | percent_format }} | `{{ liquidity_evidence }}` |

### 6.2 Investor Liquidity Terms

| Redemption Frequency | Notice Period | Gate | Lock-up |
|----------------------|---------------|------|---------|
| {{ redemption_frequency }} | {{ notice_period }} | {{ gate_provision }} | {{ lockup_period }} |

---

{# ============================================ #}
{# SECTION 7: EVIDENCE APPENDIX #}
{# ============================================ #}

## 7. Evidence Appendix

### 7.1 Data Sources

| Source | Description | As-of Date | Hash |
|--------|-------------|------------|------|
{% for source in data_sources %}
| {{ source.name }} | {{ source.description }} | {{ source.as_of | date_format }} | `{{ source.hash }}` |
{% endfor %}

### 7.2 Calculation Audit Trail

| Calculation | Input Evidence | Output Evidence | Verified |
|-------------|----------------|-----------------|----------|
{% for calc in calculations %}
| {{ calc.name }} | `{{ calc.input_hash }}` | `{{ calc.output_hash }}` | {{ calc.verified }} |
{% endfor %}

---

## Preparer Certification

I certify that the information contained in this workpaper is accurate and complete based on the evidence cited.

**Prepared By:** {{ prepared_by }}  
**Date:** {{ prepared_at | date_format }}  
**Document Hash:** `{{ document_hash }}`  

---

**CONFIDENTIAL - SEC FILING SUPPORT DOCUMENTATION**
